Publications by authors named "Ellinor Elinder"

Claim this Profile
R
Randomized Multicenter Trial of Acupressure in Patients Undergoing Moderately to Highly Emetogenic Chemotherapy.
Delmy Oliva, Mats Nilsson, Elsy-Britt Schildt, Lisa Fust, Emma Larsson, Ellinor Elinder

Clin J Oncol Nurs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.
Pia Mouhanna, Anders Ståhlberg, Daniel Andersson, Ahmed Albu-Kareem, Ellinor Elinder

Int J Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
Yajing Zhu, Ioannis Zerdes, Alexios Matikas, Ivette Raices Cruz, Mattias Bergqvist, Ellinor Elinder

Breast Cancer Res Treat· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo- or Adjuvant Chemotherapy: A Randomised Multicentre Phase II Study. (EudraCT: 2015-000658-39).
Delmy Oliva, Bengt-Åke Andersson, Levar Shamoun, Nongnit Lewin, Mats P Nilsson, Ellinor Elinder

Anticancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.
Alexios Matikas, Hemming Johansson, Per Grybäck, Judith Bjöhle, Balazs Acs, Ellinor Elinder

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.
Thomas Hatschek, Theodoros Foukakis, Judith Bjöhle, Tobias Lekberg, Hanna Fredholm, Ellinor Elinder

JAMA Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis